Stefanie Deuster
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Antibiotic Use and Resistance
Papers in
-
- Nanoparticle-Based Drug Delivery 3
- Electrospun Nanofibers in Biomedical Applications 1
-
- Muscle Physiology and Disorders 2
- Co-authors
- Christoph Mamot (3 shared papers)Christoph Rochlitz (3 shared papers)Reto Ritschard (3 shared papers)Andreas Wicki (2 shared papers)Lukas Bubendorf (2 shared papers)Thomas Dieterle (2 shared papers)Richard Herrmann (1 shared paper)Michael Sinnreich (2 shared papers)
- Journals
- PLoS ONE (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Trials (1 paper)The Lancet Oncology (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- SwitzerlandUnited KingdomCanada
In The Last Decade
Stefanie Deuster
14 papers receiving 409 citations
Peers
Comparison fields: 5 of 91
- Biomaterials 161
- Applied Microbiology and Biotechnology 19
- Molecular Biology 183
- Geriatrics and Gerontology 8
- Biomedical Engineering 107
Countries citing papers authored by Stefanie Deuster
This map shows the geographic impact of Stefanie Deuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Deuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Deuster more than expected).
Fields of papers citing papers by Stefanie Deuster
This network shows the impact of papers produced by Stefanie Deuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Deuster. The network helps show where Stefanie Deuster may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefanie Deuster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 208 | |
| 2 | 2016 | 69 | |
| 3 | 2009 | 38 | |
| 4 | 2015 | 36 | |
| 5 | 2012 | 27 | |
| 6 | 2011 | 13 | |
| 7 | 2011 | 10 | |
| 8 | 2020 | 7 | |
| 9 | 2017 | 4 | |
| 10 | 2015 | 3 | |
| 11 | 2019 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 1 |
About Stefanie Deuster
Stefanie Deuster is a scholar working on Biomaterials, Molecular Biology, Oncology, Pharmacology and Cellular and Molecular Neuroscience, having authored 14 papers that have together received 420 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Muscle Physiology and Disorders (2 papers), HER2/EGFR in Cancer Research (2 papers), Antibiotic Use and Resistance (1 paper), Epilepsy research and treatment (1 paper), Electrospun Nanofibers in Biomedical Applications (1 paper), Neuroscience and Neuropharmacology Research (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Biomaterials (161 citations), Applied Microbiology and Biotechnology (19 citations), Molecular Biology (183 citations), Geriatrics and Gerontology (8 citations) and Biomedical Engineering (107 citations). Stefanie Deuster has collaborated with scholars based in Switzerland, United Kingdom and Canada. Frequent co-authors include Christoph Mamot, Christoph Rochlitz, Reto Ritschard, Andreas Wicki, Lukas Bubendorf, Thomas Dieterle, Richard Herrmann, Michael Sinnreich, Dirk Fischer and Beat Erne. Their work appears in journals such as PLoS ONE, Clinical Pharmacology & Therapeutics, Trials, The Lancet Oncology and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.